New Indication: Docetaxel as a Radiosensitizer in Patients with Head and Neck Cancer
|New Indication: Docetaxel as a Radiosensitizer in Patients with Head and Neck Cancer|
J Clin Oncol 2023: 27 JAN.
Patil V.M et al. ¨ Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation¨
Reviewed by Elvin CHALABİYEV, MD on FEB 24, 2023
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.